Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East

BACKGROUND: Evidence on the use of fingolimod in real-world clinical practice and data on patient-reported health-related quality of life (HRQoL) in countries such as the Middle East are sparse. The Prospective Evaluation of Treatment with Fingolimod for Multiple Sclerosis (PERFORMS) study assessed...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Neurol
Hlavní autoři: Achiron, Anat, Aref, Hany, Inshasi, Jihad, Harb, Mohamad, Alroughani, Raed, Bijarnia, Mahendra, Cooke, Kathryn, Yuksel, Ozgur
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5547540/
https://ncbi.nlm.nih.gov/pubmed/28784108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-017-0913-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky